Kingswood Wealth Advisors LLC Reduces Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kingswood Wealth Advisors LLC cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,850 shares of the exchange traded fund’s stock after selling 465 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $522,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Verity Asset Management Inc. lifted its holdings in SPDR S&P Biotech ETF by 7.9% during the third quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock valued at $1,258,000 after purchasing an additional 1,266 shares during the last quarter. Sowell Financial Services LLC lifted its holdings in SPDR S&P Biotech ETF by 53.3% during the second quarter. Sowell Financial Services LLC now owns 18,249 shares of the exchange traded fund’s stock valued at $1,518,000 after purchasing an additional 6,346 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in SPDR S&P Biotech ETF by 557.6% during the second quarter. Thrivent Financial for Lutherans now owns 236,081 shares of the exchange traded fund’s stock valued at $19,642,000 after purchasing an additional 200,178 shares during the last quarter. Cerity Partners LLC increased its position in shares of SPDR S&P Biotech ETF by 663.8% during the second quarter. Cerity Partners LLC now owns 83,610 shares of the exchange traded fund’s stock valued at $6,956,000 after buying an additional 72,664 shares during the period. Finally, EP Wealth Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 132.1% during the third quarter. EP Wealth Advisors LLC now owns 20,786 shares of the exchange traded fund’s stock valued at $1,518,000 after buying an additional 11,832 shares during the period.

SPDR S&P Biotech ETF Stock Up 2.4 %

Shares of XBI opened at $94.91 on Thursday. The business’s 50-day moving average price is $93.27 and its 200-day moving average price is $82.57. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The stock has a market cap of $7.28 billion, a PE ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.